Cargando…
Scaffold-Hopping from Synthetic Drugs by Holistic Molecular Representation
The discovery of novel ligand chemotypes allows to explore uncharted regions in chemical space, thereby potentially improving synthetic accessibility, potency, and the drug-likeness of molecules. Here, we demonstrate the scaffold-hopping ability of the new Weighted Holistic Atom Localization and Ent...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220272/ https://www.ncbi.nlm.nih.gov/pubmed/30405170 http://dx.doi.org/10.1038/s41598-018-34677-0 |
_version_ | 1783368792526553088 |
---|---|
author | Grisoni, Francesca Merk, Daniel Byrne, Ryan Schneider, Gisbert |
author_facet | Grisoni, Francesca Merk, Daniel Byrne, Ryan Schneider, Gisbert |
author_sort | Grisoni, Francesca |
collection | PubMed |
description | The discovery of novel ligand chemotypes allows to explore uncharted regions in chemical space, thereby potentially improving synthetic accessibility, potency, and the drug-likeness of molecules. Here, we demonstrate the scaffold-hopping ability of the new Weighted Holistic Atom Localization and Entity Shape (WHALES) molecular descriptors compared to seven state-of-the-art molecular representations on 30,000 compounds and 182 biological targets. In a prospective application, we apply WHALES to the discovery of novel retinoid X receptor (RXR) modulators. WHALES descriptors identified four agonists with innovative molecular scaffolds, populating uncharted regions of the chemical space. One of the agonists, possessing a rare non-acidic chemotype, revealed high selectivity on 12 nuclear receptors and comparable efficacy as bexarotene on induction of ATP-binding cassette transporter A1, angiopoietin like protein 4 and apolipoprotein E. The outcome of this research supports WHALES as an innovative tool to explore novel regions of the chemical space and to detect novel bioactive chemotypes by straightforward similarity searching. |
format | Online Article Text |
id | pubmed-6220272 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-62202722018-11-08 Scaffold-Hopping from Synthetic Drugs by Holistic Molecular Representation Grisoni, Francesca Merk, Daniel Byrne, Ryan Schneider, Gisbert Sci Rep Article The discovery of novel ligand chemotypes allows to explore uncharted regions in chemical space, thereby potentially improving synthetic accessibility, potency, and the drug-likeness of molecules. Here, we demonstrate the scaffold-hopping ability of the new Weighted Holistic Atom Localization and Entity Shape (WHALES) molecular descriptors compared to seven state-of-the-art molecular representations on 30,000 compounds and 182 biological targets. In a prospective application, we apply WHALES to the discovery of novel retinoid X receptor (RXR) modulators. WHALES descriptors identified four agonists with innovative molecular scaffolds, populating uncharted regions of the chemical space. One of the agonists, possessing a rare non-acidic chemotype, revealed high selectivity on 12 nuclear receptors and comparable efficacy as bexarotene on induction of ATP-binding cassette transporter A1, angiopoietin like protein 4 and apolipoprotein E. The outcome of this research supports WHALES as an innovative tool to explore novel regions of the chemical space and to detect novel bioactive chemotypes by straightforward similarity searching. Nature Publishing Group UK 2018-11-07 /pmc/articles/PMC6220272/ /pubmed/30405170 http://dx.doi.org/10.1038/s41598-018-34677-0 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Grisoni, Francesca Merk, Daniel Byrne, Ryan Schneider, Gisbert Scaffold-Hopping from Synthetic Drugs by Holistic Molecular Representation |
title | Scaffold-Hopping from Synthetic Drugs by Holistic Molecular Representation |
title_full | Scaffold-Hopping from Synthetic Drugs by Holistic Molecular Representation |
title_fullStr | Scaffold-Hopping from Synthetic Drugs by Holistic Molecular Representation |
title_full_unstemmed | Scaffold-Hopping from Synthetic Drugs by Holistic Molecular Representation |
title_short | Scaffold-Hopping from Synthetic Drugs by Holistic Molecular Representation |
title_sort | scaffold-hopping from synthetic drugs by holistic molecular representation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220272/ https://www.ncbi.nlm.nih.gov/pubmed/30405170 http://dx.doi.org/10.1038/s41598-018-34677-0 |
work_keys_str_mv | AT grisonifrancesca scaffoldhoppingfromsyntheticdrugsbyholisticmolecularrepresentation AT merkdaniel scaffoldhoppingfromsyntheticdrugsbyholisticmolecularrepresentation AT byrneryan scaffoldhoppingfromsyntheticdrugsbyholisticmolecularrepresentation AT schneidergisbert scaffoldhoppingfromsyntheticdrugsbyholisticmolecularrepresentation |